| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 04/07/2004 | EP1404339A2 Method for treating fibrotic diseases or other indications vi |
| 04/07/2004 | EP1404330A1 Substituted 8-arylquinoline pde4 inhibitors |
| 04/07/2004 | EP1404323A1 Use of methylnaltrexone to treat immune suppression |
| 04/07/2004 | EP1150991B1 Compositions for treating inflammatory response |
| 04/07/2004 | CN1487940A Lactam compounds and medicinal use thereof |
| 04/07/2004 | CN1487938A Quinuclidine derivatives and their use as M3 antagonists |
| 04/07/2004 | CN1487933A Pyrazole compounds useful as protein kinase inhibitors |
| 04/07/2004 | CN1487931A Naphthostyrils compounds |
| 04/07/2004 | CN1487927A Diaminothiazoles |
| 04/07/2004 | CN1487831A Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mGluR1 antagonists |
| 04/07/2004 | CN1487830A Use of 6-dimethylaminomethy1-1-pheny1-cyclohexane compounds for treating urinary incontinence |
| 04/07/2004 | CN1486969A Composite mineral salf of potassium-magnesium hydrogen citrate and its prepn process |
| 04/07/2004 | CN1486733A Application of Chinese lizardtail herb and its extractive in preventing and treating prostatosis |
| 04/07/2004 | CN1486706A Medicine of treating nephrotic syndrome |
| 04/07/2004 | CN1144804C Benzo[C] quinolizine derivatives and their use as 5 alpha-reductases inhibitors |
| 04/07/2004 | CN1144799C N-(iminomethyl) amine derivatives, their preparation, their use as medicines and medical compositions containing the same |
| 04/07/2004 | CN1144794C Benzoxazine and benzothiazine derivatives and their application in medicines |
| 04/07/2004 | CN1144790C Telmisartan polymorphs, producing process thereof and use in prepn. of pharmaceutical composition thereof |
| 04/07/2004 | CN1144788C Bicycle vasporession agonists |
| 04/07/2004 | CN1144786C Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 04/07/2004 | CN1144785C Hydroxamic acid and its preparation, and pharmaceutical composition |
| 04/06/2004 | US6716978 For therapy and prohylaxis of inflammatory diseases including joint inflammation, crohn's disease, and inflammatory bowel disease; respiratory diseases such as chronic obstructive pulmonary disease (copd) including asthma, chronic bronchitis |
| 04/06/2004 | US6716872 Using the compounds for treating pain, anxiety and various other diseases or conditions. |
| 04/06/2004 | US6716871 Cyclic AMP-specific phosphodie sterase inhibitors |
| 04/06/2004 | US6716870 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 04/06/2004 | US6716852 Amino acid derivatives and use thereof as NEP, ACE and ECE inhibitors |
| 04/06/2004 | US6716828 Treatment or prevention of neural or cardiovascular tissue damage related to cerebral ischemia and reperfusion injury in an animal by administering poly(adp- ribose) polymerase (?parp?) inhibitors. |
| 04/06/2004 | US6716818 Caspase inhibitors and the use thereof |
| 04/06/2004 | US6716586 Insulin-like growth factor agonist molecules |
| 04/06/2004 | US6716413 Indole compounds as tissue-specific exogenous optical agents |
| 04/06/2004 | CA2359061C Crystal polymorphism of aminoethylphenoxyacetic acid derivative |
| 04/06/2004 | CA2091134C Therapeutic agent for threatened abortion |
| 04/01/2004 | WO2004026874A1 Novel crystals of triazaspiro[5.5]undecane derivative |
| 04/01/2004 | WO2004026873A1 Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient |
| 04/01/2004 | WO2004026833A1 Cyclic amine compound, process for producing the same, and use |
| 04/01/2004 | WO2004026832A1 Urea compound and use thereof |
| 04/01/2004 | WO2004026815A2 Phenol derivatives and their use as rotamase inhibitors |
| 04/01/2004 | WO2004026312A1 Use of a quinazoline derivative for treating lower urinary tract symptoms |
| 04/01/2004 | WO2004026300A1 COMBINATIONS OF ATORVASTATIN AND α1, ADRENERGIC RECEPTOR ANTAGONISTS |
| 04/01/2004 | WO2003106425A3 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity |
| 04/01/2004 | WO2003101932A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 04/01/2004 | WO2003099819A3 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics |
| 04/01/2004 | WO2003099771A3 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases |
| 04/01/2004 | WO2003099284B1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 04/01/2004 | WO2003097799A3 HTLV-I TAX INDUCED KILLING OF p53 NULL CANCER CELLS |
| 04/01/2004 | WO2003097658A3 Compounds and methods for inhibiting selectin-mediated function |
| 04/01/2004 | WO2003097597A3 Indole derivatives and the use thereof as cb2 receptor ligands |
| 04/01/2004 | WO2003084943A3 Terphenyl derivatives, preparation thereof, compositions containing same |
| 04/01/2004 | WO2003082874A3 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 04/01/2004 | WO2003082314A3 Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1) |
| 04/01/2004 | WO2003070886A3 Inhibition of protein tyrosine phosphatase type iva expression byshort interfering nucleic acid |
| 04/01/2004 | WO2003049675A3 Treating muscle wasting with selective androgen receptor modulators |
| 04/01/2004 | WO2003008410A8 Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression |
| 04/01/2004 | WO2002098852A8 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins |
| 04/01/2004 | WO2002085897A9 Heterocyclic compounds for aging-related and diabetic vascular complications |
| 04/01/2004 | WO2002076402A3 Fatty amine drug conjugates |
| 04/01/2004 | WO2002070676A9 Use of protein histidine phosphatase |
| 04/01/2004 | US20040063950 Carbamates derivatived from arylakylamines |
| 04/01/2004 | US20040063949 Controlling gene expression of tranforming growth factor |
| 04/01/2004 | US20040063946 Jnk inhibitor |
| 04/01/2004 | US20040063944 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 04/01/2004 | US20040063943 Phosphodiesterase inhibitor; cardiovascular disorders; sexual disorders |
| 04/01/2004 | US20040063942 Spiro-indolines as Y5 receptor antagonists |
| 04/01/2004 | US20040063914 Antibodies against phosphorylated VASP ( vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use |
| 04/01/2004 | US20040063913 Antibodies to human il-1beta |
| 04/01/2004 | US20040063785 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use |
| 04/01/2004 | US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes |
| 04/01/2004 | US20040063781 Compounds active at the glucocorticoid receptor II |
| 04/01/2004 | US20040063731 Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidines and endothelin receptor antagonists or thienopyrimidines and endothelin receptor antagonists |
| 04/01/2004 | US20040063730 Such as 5-(7-(3-chloro-4-methoxybenzylamino-1-methyl-3-propyl-1 H-pyrazolo(4,3-d)pyrimidin-5-yl)pentanoic acid; phosphodiesterase inhibitors; for treatment of cardiovascular disorders, asthma, and allergies; kits |
| 04/01/2004 | US20040063709 Acute and chronic inflammatory disorders; cancer |
| 04/01/2004 | US20040063708 Pyrrolotriazine kinase inhibitors |
| 04/01/2004 | US20040063707 Azaindole kinase inhibitors |
| 04/01/2004 | US20040063701 Potent and specific serotonin 2 receptor inhibition with low adverse side effects; such as 1-formyl-N-(2-(4-(5H-dibenzo-(a,d)cyclohepten-5-ylidene)-1 -piperidinyl))ethylisonipecot-amide |
| 04/01/2004 | US20040063693 5-HT2A receptor related disorders; such as 1-(2-(2-fluoro-4-nitrophenoxy)ethyl)-3-(1piperazinyl)-2(1H)-pyrazinone |
| 04/01/2004 | US20040063690 Cardiovascular disorders; guanylate cyclase activation; diseases associated with disturbed cyclic guanosine monophosphate balance |
| 04/01/2004 | US20040063688 CCR1 receptor antagonists; such as 5-chloro-2-(2-(-3-(4-fluoro-phenoxy)-8-aza-bicyclo(3.2.1)oct-8-yl)-2-oxo -ethoxy)-benzamide |
| 04/01/2004 | US20040063687 Cardiac arrhythmias; potassium channel function inhibitors; such as 7-(3,4-Dichlorophenyl)-6-(5-fluoro-1-methyl-1H-benzimidazol-2-yl)-4,7 -dihydro-5-(methoxymethyl)pyrazolo-(1,5-a)pyrimidine |
| 04/01/2004 | US20040063679 Amidino and guanidino peptidyl compounds; autoimmune diseases |
| 04/01/2004 | US20040063655 Antisense modulation of transforming growth factor-beta expression |
| 04/01/2004 | US20040063647 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors |
| 04/01/2004 | US20040063644 Urea and urethane derivatives as integrin inhibitors |
| 04/01/2004 | US20040063621 Heterocarpine, a human ghrh-binding protein |
| 04/01/2004 | US20040062810 Removal blockage in blood vessels; mixture of angiogenesis inhibitor and polymer |
| 04/01/2004 | US20040060865 Buffered compositions for dialysis |
| 04/01/2004 | CA2498894A1 Combinations of atorvastatin and .alpha.1, adrenergic receptor antagonists |
| 04/01/2004 | CA2498662A1 Phenol derivatives and their use as rotamase inhibitors |
| 04/01/2004 | CA2497903A1 Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient |
| 04/01/2004 | CA2495311A1 Use of a quinazoline derivative for treating lower urinary tract symptoms |
| 03/31/2004 | EP1403270A1 Pde iv inhibitors |
| 03/31/2004 | EP1403256A1 Fused imidazole derivative |
| 03/31/2004 | EP1403255A1 Rho KINASE INHIBITORS |
| 03/31/2004 | EP1403235A1 N-arylphenylacetamide derivatives and medicinal compositions containing the same |
| 03/31/2004 | EP1402896A1 Green tea extract and use thereof in treating renal dysfunction |
| 03/31/2004 | EP1402888A1 The use of substituted carbocyclic compounds as rotamases inhibitors |
| 03/31/2004 | EP1402018A1 Unigene unidirectional antisense library |
| 03/31/2004 | EP1402017A1 Random gene unidirectional antisense library |
| 03/31/2004 | EP1401870A2 Antibodies against tumor necrosis factor delta (april) |
| 03/31/2004 | EP1401869A1 Molecules and methods for inhibiting shedding of kim-1 |
| 03/31/2004 | EP1401862A2 Peptide compounds for counteracting reactive oxygen species and free radicals |